Category Archives: BioInformatics

San Francisco, California (PRWEB) May 28, 2014 The global market for bioinformatics is expected to reach USD 12.48 billion by 2020, according to a new study by Grand View Research, Inc. Rapidly declining prices of DNA sequencing, growing adoption rates of bioinformatics as a cost effective tool for database management during clinical trials, increasing government initiatives encouraging the use of bioinformatics in drug discovery and the use of bioinformatics tools in emerging fields such as chemogenomics are some of the factors expected to drive market growth over the next six years. In addition, the introduction of advance technologies such as nanopore and cloud computing are expected to serve this market as future growth opportunities. Bioinformatics platform products are expected to dominate the market, along with being the fastest growing segment, at an estimated CAGR of 22.8% from 2014 to 2020. The increasing demand for these platforms in technologically advanced processes such as high throughput screening for combination therapies namely pharmacogenomics and pharmacoproteomics is expected to serve this market as drivers during the forecast period. Global biocontent product demand is expected to reach USD 4.30 billion by 2020, growing at a CAGR of 16.9% from 2014 to 2020. The report Bioinformatics … Continue reading →

POCKET SCIENCE: NEW MOBILE APPLICATION ENABLES DNA ANALYSIS ON THE GO Researchers from A*STARs Bioinformatics Institute (BII) have developed the first mobile application for Android phones that analyses ab1[1] DNA sequencing files, which enables science professionals and amateur enthusiasts to engage in scientific analysis on the go, from the convenience of their mobile phones. DNA sequencing is a commonly used technique which has advanced many areas of biological research, from the understanding of genetic information to the causes and treatment of human diseases. However, analysis of DNA sequencing files used to be carried out only on computers. This frustrated Dr Samuel KE Gan, molecular cell biologist and team leader of Antibody & Product Development (APD) Laboratory, when he wanted to work when travelling. He presented the challenge to his computer science research officer Mr Nguyen Phi Vu, to find a better way to read data on the move. What resulted was the DNAApp, developed in just three months, which allowed him to read and analyse DNA sequencing files on his mobile phone. Dr Gans team published the app freely on Google Play store and Apple app store for scientists worldwide so that they too can improve their efficiency and productivity. … Continue reading →

SINGAPORE: A mobile app that analyses DNA sequencing files has been developed by researchers from the A*STARs Bioinformatics Institute (BII). DNAApp - available for free on the Android and iOS platforms - will enable science professionals and amateur enthusiasts to engage in scientific analysis while on their phones or tablets. Since its launch in April, it has been downloaded by users in more than 11 countries, said a statement released by A*STARs BII on Thursday (May 29). The app can analyse ab1 DNA sequencing files, which are files in the Applied Biosystems Genetic Analysis data file format,which could previously only be processed by a computer. The app, which took the team three months to develop, allows users to analyse visualisations of DNA sequencing files and carries out commonly used functions of DNA sequencing analysis. It can also complement existing web-based bioinformatics tools for deeper analysis. As the use of mobile devices and their applications becomes increasingly widespread, we hope to continue to be at the forefront of technology creating new bioinformatics tools for the advancement of scientific knowledge and making science accessible, said Dr Samuel K E Gan, molecular cell biologist and team leader of Antibody & Product Development (APD) … Continue reading →

The Hyve - OpenSource Bioinformatics Listen to what our CEO Kees van Bochove and our partners and clients tell about the offerings from The Hyve. See how we can help your company leverage the po... By: The Hyve … Continue reading →

Fugeneio The Fest - Fugeitorium - Bioinformatics Experience in 3D Fugeneio 2011 was the most successful event experienced by Patkar Varde College of science and it's Bioinformatics Department. Entire shoot was Done by 3D In... By: Supriya Khanolkar … Continue reading →

Contact Information Available for logged-in reporters only Newswise There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities. Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for which they were originally approved. Repurposing these drugs depends on matching drugs to targets. A study recently published in the journal Bioinformatics describes a new database and pattern-matching algorithm that allows researchers to evaluate rational drugs and drug combinations, and also recommends a new drug combination to treat drug-resistant non-small cell lung cancer. Most cancers have more than one genetic alternation. And even genetically targeted drugs tend to affect more than only their stated target. And so the challenge is matching drugs with many effects to cancers with many causes in a way that best maps the drugs effects onto the intended targets, says Aik Choon Tan, PhD, investigator at the University of Colorado Cancer Center and associate professor of Bioinformatics at the CU School of Medicine. There are about 500 kinases in the human genome, each of which represents a potentially important drug target. Tan describes the database as a spreadsheet with 500 … Continue reading →

Careers in Bioinformatics and Precision Medicine - Career Development Week Visit: http://www.uctv.tv/) Precision medicine integrates molecular and clinical research with patient data and outcomes, aiming to place the patient at the center of all elements. In this... By: University of California Television (UCTV) … Continue reading →

Wellesley, Mass., (PRWEB) May 19, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for biomarkers is expected to grow to $53.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 12.8%. The bioinformatics category, the fastest moving segment overall, is expected to move at a significant 17.4% CAGR. Targeted therapies, improved patient selection for clinical trial criteria, early drug rationalization, and proactively identifying adverse events for patients are some of the leading applications for biomarkers technologies. Genomic applications, which help to improve drug effectiveness, represents the largest segment in the overall biomarkers market and is expected to reach $26 billion in 2018. However, bioinformatics, which plays a vital role in disease analysis, as well as biomarker discovery and validation, is expected to surge from $2.3 billion in 2013 to nearly $5.2 billion by 2018. "The growth of the bioinformatics market is driven by a decrease in the cost of DNA sequencing, increasing government initiatives and funding, and growing use of bioinformatics in drug discovery and biomarkers development processes," says BCC Research biotech analyst Jackson Highsmith. "However, factors such as a dearth of skilled personnel to ensure proper use … Continue reading →

KARUNYA BIOINFORMATICS Bioinformatics: The field of technology biology combined to present a computational analysis. A very fascinating course where one can experience both wet l... By: suji bal … Continue reading →

Happy birthday Prof Usman from bioinformatics team By: metabolism class 2011 … Continue reading →